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Abstract
Purpose—To understand the relationship between choroidal thickness and various disease
factors in patients with age-related macular degeneration (AMD) using spectral-domain optical
coherence tomography.
Design—Cross-sectional, retrospective analysis.
Methods—Fifty-seven eyes of 47 patients with wet and dry AMD seen between November 2009
and January 2010 at the New England Eye Center, Boston, Massachusetts, were analyzed.
Choroidal thickness was measured by 2 independent observers at 11 sites with high-definition
horizontal 1-line raster scans through the foveal center. A retrospective chart review was
performed to obtain data concerning duration of disease, number of intravitreal anti–vascular
endothelial growth factor injections, visual acuity, lens status, and concomitant retinal pathologic
features. The Pearson correlation and Student t test were used for statistical analysis for
assessment of choroidal thickness changes in wet and dry AMD.
Results—The choroid in eyes with wet and dry AMD demonstrated a wide range of thicknesses
above and below the normal mean (range, 77.5 to 399.5 μm; standard deviation [SD], 90.2).
Nearly one third (33.3%) of the eyes with AMD measured less than 1 SD below the mean. Eyes
with wet AMD demonstrated a mean subfoveal choroidal thickness of 194.6 μm (SD, 88.4; n =
40) compared with 213.4 μm (SD, 92.2; n = 17) in the dry AMD group. The choroidal thickness in
eyes with dry AMD was correlated inversely with age (r = −0.703; P = .002); however, analysis of
the number of intravitreal anti–vascular endothelial growth factor injections, number of years of
disease, and visual acuity failed to demonstrate any significant correlations with choroidal
thickness.
Conclusions—This study demonstrated that choroidal thickness can be measured by spectral-
domain optical coherence tomography and that variable choroidal thickness exists among patients
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with the clinical diagnosis of wet and dry AMD. However, it is unclear at this time why in some
eyes, choroidal thickness either increases or decreases with the disease. Further studies need to be
carried out to understand the significance of choroidal thickness with respect to visual function
and disease progression over time.
Over the last decade, Optical Coherence Tomography (OCT) has become an integral tool in
the field of ophthalmology.1 OCT provides a so-called optical biopsy, a high-resolution,
cross-sectional, and 3-dimensional reconstructed view of the retina in vivo in a noninvasive,
reproducible manner. In comparison with the original time-domain OCT devices, newer
Fourier spectral-domain OCT permits faster scanning speeds, up to 52 000 A-scans/
second.2,3 Dense scan patterns achievable at such high speeds, along with better tissue
resolution, allow for more accurate qualitative and quantitative analysis in various macular
diseases. Improvements to existing spectral-domain OCT devices, such as frame averaging,
despeckling, and improved image contrast, provide even better definition of intraocular
structures such as choroidal tissue.4,5
Age-related macular degeneration (AMD) is the leading cause of blindness in both
developed and developing nations in patients older than 60 years.6–8 OCT generated
macular thickness maps have been proven to be useful in monitoring the progression and
response to treatment in wet AMD after anti–vascular endothelial growth factor (VEGF)
treatment; however, little currently is known about the choroids of patients with AMD.9
The choroid in normal and disease states has been investigated by using eye tracking
software, frame averaging, and image inversion to visualize the full choroidal
thickness10–16; alternatively, the choroid has been measured using a device that uses
increased wavelength for better choroidal signal penetration.17 It is only with the availability
of the latest software upgrades of both the Heidelberg Spectralis (Heidelberg Engineering,
Heidelberg, Germany) and Cirrus-HD OCT (Carl Zeiss Meditec, Dublin, California, USA)
spectral-domain devices that choroidal depth now can been visualized routinely by
clinicians. Studies have demonstrated changes in choroidal structure with increasing age and
conditions such as high myopia and central serous chorioretinopathy (CSCR)11–14,16,17;
however, the choroidal structure in patients with AMD has not been examined. The goal of
this study was to characterize choroidal thickness in patients with AMD using spectral-
domain OCT and to compare the eyes to age-matched normal volunteers.
Methods
A retrospective review was performed on 57 eyes of 47 patients with the clinical diagnosis
of either wet or dry AMD seen between November 2009 and January 2010 at the New
England Eye Center, Tufts Medical Center, Boston, Massachusetts. All patients included in
the study underwent a comprehensive ophthalmologic examination with fundus
biomicroscopy, color fundus photography, best-corrected Snellen visual acuity, fluorescein
angiography, and OCT. OCT imaging was performed using Cirrus-HD OCT software
version 4.5. The software version allows for the acquisition of high-definition 1-line raster
scans that are constructed from 20 B-scans obtained at the same location and processed
using a unique Selective Pixel Profiling system (Cirrus HD-OCT; Carl Zeiss Meditec). The
1-line raster is a 6-mm line consisting of 4096 A-scans, with an axial resolution of
approximately 5 to 6 μm and a transverse resolution of approximately 15 to 20 μm. These
high-definition images provide increased definition of retinal layers, as well as more
posterior structures, such as the choroid–sclera junction. The images were not inverted to
bring the choroid in closer proximity to the 0 delay line, as has been described previously as
a tool to visualize better the choroid.10 Nevertheless, in most cases, good-quality images
were obtainable, allowing choroidal thickness measurements to be performed. All images
Manjunath et al. Page 2
Am J Ophthalmol. Author manuscript; available in PMC 2012 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
included in this study were at least 6 of 10 in intensity, taken as close to the fovea as
possible, and able to demonstrate clear visualization of the choroid–sclera boundary.
Choroidal thickness measurements were obtained manually using the Cirrus linear
measurement tool at 500-μm intervals, 2500 μm temporal and nasal to the fovea,
perpendicular from the base of the hyperreflective retinal pigment epithelium to the
choroid–sclera junction. In 9 eyes with choroidal neovascularization, measurements were
performed from the edge of the Bruch membrane to the top of the sclera (Figure 1). The 11
measurements were obtained from all 57 eyes by 2 independent observers (V.M., J.G.) to
correlate the thickness measurements. Chart review was performed to collect information
regarding duration of disease, treatments, number of intravitreal anti-VEGF injections,
visual acuity (VA), lens status, and concomitant retinal pathologic features. Eyes with more
than −6 diopters of refractive error were excluded because of known choroidal thinning
associated with high myopia.13
All statistics were calculated using SPSS software version 17.0 for Windows (SPSS, Inc,
Chicago, Illinois, USA). Pearson correlation and the Student t test were used to correlate
interobserver measurements and to correlate choroidal thickness values with various disease
factors. A P value of < .05 was considered statistically significant in this study.
Results
The Study Group Included 23 Males (40%) and 34 Females (60%). Forty eyes (70%) had
the diagnosis of wet AMD with a mean age of 78.6 years (standard deviation [SD], 7.0
years). Seventeen eyes (30%) had dry AMD with a mean age of 78.2 years (SD, 7.9 years).
AMD is defined as a chronic, progressive degenerative disorder of the macula that affects
older individuals and features central visual loss as a result of drusen deposition, geographic
atrophy, serous detachment of the retinal pigment epithelium, and neovascularization.
Patients were subclassified as having dry AMD if there was no evidence of
neovascularization such as intraretinal or subretinal fluid at any visit time point. This group
included patients with geographic atrophy, drusen, and pigment epithelial detachments.
Patients were subclassified as having wet AMD if there was evidence of neovascularization
such as intraretinal or subretinal fluid at any visit time point. Patients were treated by
different attending physicians with a combination of treat-and-extend and as-needed
regimens with standard anti-VEGF therapy. Of the 40 eyes with wet AMD, 7 of these
patients had undergone prior photodynamic therapy at least once in the study eye. The
average duration of disease was 3.8 years. Subfoveal choroidal thickness measurements
were used for comparative purposes in this study. The pattern of choroidal thickness in the
macula in the 57 eyes with AMD in this study demonstrated the thickest choroid located
subfoveally, with nasal and temporal thinning, maintaining a similar pattern seen in normal
eyes (Figure 2).11,16
The authors' recent paper demonstrated a mean subfoveal choroidal thickness of 272 ± 81
μm in normal eyes using the Cirrus HD-OCT 1-line raster scan in patients with an average
age of 51.1 years.16 In a study utilizing the Heidelberg Spectralis, normal subfoveal
choroidal thickness of 287 ± 76 μm in patients with a mean age of 50.4 years was
reported.11 The mean age of the 57 eyes in this study was 78.4 years (SD, 7.3 years);
therefore, an age-adjusted normal subfoveal choroidal thickness of 229 μm was used for
comparison because of an approximate 1.56-μm decline in choroidal thickness per year of
life.11 A strong interobserver correlation of choroidal thickness measurements in all 57 eyes
was found at each of the 11 locations measured along the horizontal scans of the macula.
The correlation values of interobserver measurements ranged from 0.909 to 0.981, with P
values of < .01 at each of the 11 measured points. The subfoveal choroidal measurements
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performed on the Cirrus HD-OCT 1-line raster images by the 2 separate observers (V.M.,
J.G.) were averaged.
The results of the choroidal thickness measurements in the 57 eyes with wet and dry AMD
demonstrated considerable variation in thickness. The measurements were plotted according
to SDs from the mean age-adjusted normal subfoveal choroidal thickness (Figure 3).
Twenty-seven eyes (47.3%) fell outside the range of 1 SD from the mean and 2 eyes (3.5%)
had significantly thickened choroids, measuring more than 2 SDs above the mean. Of the 2
eyes more than 2 SDs above the mean, 1 eye was categorized as having dry AMD and 1 was
categorized as having wet AMD (Figure 4).
Mean subfoveal choroidal thickness was found to be 194.6 μm (SD, 88.4; n = 40) in the wet
AMD group and 213.4 μm (SD, 92.2; n = 17) in the dry AMD group. A weak correlation (r
= −0.367; P = .005) was found between subfoveal choroidal thickness and age when all 57
eyes were considered together. However, when analyzed separately, eyes with wet AMD
showed a weak correlation with age (r = −0.203; P = .208) that was not statistically
significant, whereas eyes with dry AMD demonstrated a statistically significant correlation
(r = −0.703; P = .002). This relationship in dry eyes was found to be stronger than the
correlation between subfoveal choroidal thickness and age found in normal eyes (r = −0.61;
P = .0001).16
Analysis of the relationship between the number of intravitreal anti-VEFG injections (mean
number of injections, 5.4; SD, 4.6) and subfoveal choroidal thickness in the eyes with wet
AMD demonstrated no correlation (r = −0.037; P = .821). Correlation of disease duration
defined as the number of years since initial diagnosis of macular degeneration (mean
number of years of disease, 3.8; SD, 2.7 years) also demonstrated no relationship (r =
−0.046; P = .737) with subfoveal choroidal thickness. In subgroup analysis, there was no
significant correlation found between duration of disease and choroidal thickness within the
wet AMD group (r = −0.066; P = .684) or the dry AMD group (r = 0.134; P = .608) with
relation to disease duration and choroidal thickness.
Analysis also was performed to examine the relationship between VA and subfoveal
choroidal thickness. All Snellen visual acuities were converted to logarithm of the minimal
angle of resolution (logMAR) for statistical analysis. Overall mean VA was 20/65 (logMAR
units, 0.52). Within the subgroups, the wet eyes had a mean VA of 20/71 (logMAR units,
0.55), whereas the dry eyes had a mean VA of 20/54 (logMAR units, 0.43). No correlation
was found overall (r = −0.009; P = .948) between choroidal thickness and VA, nor within
the wet AMD eyes (r = −0.126; P = .446) and dry AMD eyes (r = 0.245; P = .327) when
analyzed separately.
Discussion
The Choroid is a Highly Vascular Structure that varies in thickness with intraocular and
perfusion pressure and is subject to regulation by various vasoactive factors, including nitric
oxide, endothelins, and autonomic innervation.18–23 The choroid provides nutrients to the
photoreceptors and removes waste products from the retinal pigment epithelium. The
macula is the region of highest metabolic demand in the retina, and this has been postulated
to be the reason for the greatest choroidal thickness beneath the fovea.
Choroidal structure is of particular interest in AMD because abnormalities of the choroidal
circulation have been hypothesized to contribute to the development of AMD.24 Some
studies suggest that AMD may be a vascular disease, with inadequate choroidal perfusion
leading to hypoxia and ischemia of the retinal pigment epithelium with the subsequent
production of VEGF, which ultimately may lead to the formation of choroidal
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neovascularization.25,26 Studies using Doppler techniques also have shown that foveolar
choroidal blood flow in normal eyes decreases with increasing age.27 Compared with
normal eyes, eyes with dry AMD have been shown to have decreased blood volume and
abnormal flow and further worsening of blood flow with increasing disease severity.24,28,29
The decreased blood flow observed in the eyes of patients with AMD has been theorized to
be a combination of narrowing of the choriocapillaries lumen, loss of cellularity, and
thinning of the choroid, especially the choriocapillaries layer.24 Furthermore, decreased
nitric oxide has been demonstrated in patients with AMD, presumably leading to
vasoconstriction and hypoxia.30 Therefore, it is not unexpected that roughly one third of the
patients in this study had thinner than average choroids compared with those of age-matched
normal volunteers, possibly suggesting a role for choroidal thinning in the pathogenesis or
progression of AMD.
Certainly, the choroid has a dynamic role in the pathogenesis of AMD, and up to this point
there have been few studies examining the thickness of the choroid in AMD. This study
implements the latest in OCT imaging to measure choroidal thickness to understand better if
the observed changes can be related to disease progression and to aid in the identification of
those patients with AMD who are at greater risk of advanced disease.
The results of this study demonstrated variation of OCT choroidal measurements among
patients with the clinical diagnosis of AMD. Half (50.8%) of the measured eyes
demonstrated choroid thickness of more than 1 SD away from the mean, with 33% of the
eyes having thinner choroids than age adjusted normal eyes, and a small subset of eyes
(3.5%) having choroidal thickness of more than 2 SDs above the mean.
The eyes with a thicker choroid were re-examined to see if there were any unique
characteristics about this group. Based on the OCT appearance, it is difficult to determine
whether these patients with a thicker choroid are a variant of normal, belong to a unique
subset of AMD, or have a different disease entity altogether, such as chronic CSCR, which
reportedly features very thick choroid.14 Examination of fundus photographs and fluorescein
angiography of the eyes with increased choroidal thickness in this study dating back to the
initial visit did not demonstrate any obvious characteristic changes suggesting the diagnosis
of CSCR or polypoidal choroidal vasculopathy. Based on clinical appearance, chronic
CSCR in elderly patients, however, is not differentiated easily from wet AMD; assessing
choroidal thickness by OCT may help to distinguish these 2 possible diagnoses.
Overall, the wet AMD group demonstrated an average subfoveal choroidal thickness of
194.6 μm (n = 40), whereas the dry AMD patients had an average thickness of 213.4 μm (n
= 17). One could postulate that continued thinning of the choroid secondary to disease
progression may cause the conversion from dry to wet form of AMD. The eyes with dry
AMD demonstrated a correlation between choroidal thickness and age (r = −0.703; P = .
002), with the older patients having thinner choroids, similar to normal patients.11 However,
the eyes with wet AMD demonstrated a weaker correlation between choroidal thickness and
age, which may indicate a change in the pathophysiologic process occurring as eyes convert
from dry to wet AMD or alternatively may be a result of the small sample size and
variability in the choroid of these patients. Spraul and associates reported a difference in the
density and diameter of choroidal blood vessels in eyes with and without AMD with an
increased choriocapillaries density in the submacular area of eyes with advanced AMD.31
The present study found no correlations between choroidal thickness and the number of
intravitreal anti-VEGF injections, duration of time since first diagnosis, and visual acuity. It
is difficult to draw conclusions from these results because of the cross-sectional design of
this study, because it is unknown if there have been changes in choroidal thickness over time
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in our study eyes. Moreover, it may also be that these factors do not play a role in choroidal
thickness in AMD and that further studies are needed to investigate alternative features of
the disease to explain these differences.
There are important limitations to this study. This study is a retrospective review of
nonconsecutive patients who already carried the diagnosis of AMD. Patients were excluded
from this study if full choroidal thickness was unable to be visualized adequately to perform
the 11 measurements as described above. One hundred fifty eyes of patients with AMD were
assessed to identify 57 eyes (38%) that could be measured reliably and could be included in
this study. The fact that so many eyes were excluded because of poor acquisition may make
the data less reliable. Some eyes with an extremely thickened choroid were excluded
because of poor visualization of the choroid–sclera junction as a result of signal roll off
distal to the 0-delay line, the point of highest signal detection. Therefore, it is likely that
insufficient signal penetration artificially lowered the total number of eyes in the thickest
choroid group. In addition, with no automated computer software available to calculate
choroidal thickness, 2 independent observers performed the measurements manually, which
may limit accuracy; however, the strong interobserver correlations between measurements
suggests that this is unlikely. In addition, patients with more than 6 diopters of myopia were
excluded from the study because of the known association of high myopia and choroidal
thinning.13 Even with the exclusion of high myopes, the lack of axial length measurements
and average refractive error does weaken the data and its interpretation.
Using the newest OCT software, which enables measurement of choroidal thickness, this
study demonstrates variable choroidal thickness among groups of patients carrying the same
diagnosis. Most AMD patients in this study demonstrated thinner choroids than age-adjusted
normal volunteers; one third of these patients have choroidal thinning of 1 SD or more
below the mean. Eyes with wet AMD demonstrated thinner average choroidal thickness than
eyes with dry AMD. No direct correlation was observed between choroidal thickness and
duration of disease, number of intravitreal anti-VEGF injections, or visual acuity.
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Figure 1.
Choroidal thickness measurement in age-related macular degeneration. Cirrus HD optical
coherence tomography (OCT) 1-line raster scan demonstrating measurement technique used
to obtain choroidal thickness across the macula. This OCT scan also demonstrates the
measurement from the edge of the Bruch membrane to the choroid–sclera junction in eyes
with wet age-related macular degeneration and pigment epithelial detachments.
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Figure 2.
Graph showing mean macular choroidal thickness in eyes with age-related macular
degeneration. Mean thickness at each of the 11 locations measured at 500-μm (0.5-mm)
intervals temporal (T) and nasal (N) to the fovea (F) in all 57 eyes. The graph illustrates
variation in choroidal thickness across the macula with the choroid thinnest nasally,
thickening subfoveally, and thinning again temporally.
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Figure 3.
Bar graph showing the distribution of subfoveal choroidal thickness in eyes with wet and
dry age-related macular degeneration. The distribution of mean subfoveal choroidal
thickness measurements in the studied eyes with wet and dry age-related macular
degeneration is compared with a normal age-adjusted mean of 229 μm, with a standard
deviation of 81 μm, based on recently published data.16 Dark gray column = wet age-related
macular degeneration; light gray column = dry age-related macular degeneration.
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Figure 4.
Choroidal thickness measured to be >2 standard deviation above the mean in age-related
macular degeneration. (Top left) Color fundus photograph and (Top right) high-definition
Cirrus HD-OCT 1-line raster scan demonstrating thickened choroid in an 84-year-old
woman with a history of wet age-related macular degeneration. (Bottom left) Color fundus
photograph and (Bottom right) high-definition Cirrus HD-OCT 1-line raster scan
demonstrating increased choroidal thickness in a 71-year-old woman with a history of dry
age-related macular degeneration.
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